VENITA EDWARDS-TALLEY
Allopathic & Osteopathic Physicians|Internal Medicine GAINESVILLE, FL NPI 1932207131
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL PFIZER INC. All categories
General Payments — all program years on this page
$179.61
- Category: General Payments
- Program years: PY2018
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $179.61 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $179.61 | 9 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $79.23 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.44 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.04 | 1 |
| Amgen Inc. | $12.86 | 1 |
| Novo Nordisk AS | $11.97 | 1 |
| Lilly USA, LLC | $11.60 | 1 |
| Merck Sharp & Dohme Corporation | $11.47 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $179.61 | 9 |
Records — PY2018 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 559891497 | Lilly USA, LLC | $11.60 | 03/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 568631213 | Amgen Inc. | $12.86 | 02/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 578459606 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15.04 | 01/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 587798689 | Novo Nordisk Inc | $11.97 | 03/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 604195549 | Merck Sharp & Dohme Corporation | $11.47 | 01/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608030921 | Novartis Pharmaceuticals Corporation | $37.44 | 04/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 610281623 | PFIZER INC. | $50.73 | 03/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 610568829 | PFIZER INC. | $14.07 | 01/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 610578585 | PFIZER INC. | $14.43 | 03/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.